Addus HomeCare reported second-quarter 2026 net income of US$27.61 million and diluted earnings per share from continuing operations of US$1.49, both higher than the same period in 2025. Non-GAAP earnings per share modestly outpaced analyst expectations while the company maintained an 11.5% adjusted operating margin, underscoring consistent profitability on essentially flat margins year over year. The earnings beat supports the investment narrative of resilient demand for home-based care, though reimbursement uncertainty and staffing costs remain key risks. Addus was also removed from several Russell growth indexes in late June 2026, a technical change that may influence near-term trading and liquidity.
Addus HomeCare CorporationQ2 earnings beat estimates with steady margins, supporting profitability narrative.